 DUBLIN , Oct. 14, 2022 PRNewswire -- Medtronic plc NYSE:MDT, a global leader in healthcare technology, today announced the company will host a webcast to provide an update on its Medtronic Coronary and Renal Denervation business during the American Heart Association annual scientific sessions AHA 2022 on Monday, November 7, 2022, at 5 p.m. CST. The webcast will feature remarks from Medtronic Coronary and Renal Denervation management, including comments on the 6-month results from the SPYRAL HTN-ON MED Randomized Trial ON MED. 